Showing results (131-140 of 376) with videos related to

Sort By:
Pageof 38
Therapeutic Advances in Gastroenterology|August 25, 2022
Gastrointestinal manifestations of long COVID: A systematic review and meta-analysisArup Choudhury, Raseen Tariq, Anuraag Jena, et al.
Annals of Gastroenterology|January 30, 2026
Bezlotoxumab for prevention of <i>Clostridioides difficile</i> recurrence in patients with inflammatory bowel disease: a retrospective multicenter experienceChristian Karime, Tarek Odah, Jana G Hashash, et al.
Journal of Clinical Gastroenterology|August 13, 2019
Clostridium difficile Infection in the Emergency DepartmentSushil K Garg, Itegbemie Obaitan, Shashank Sarvepalli, et al.
Alimentary Pharmacology & Therapeutics|August 3, 2016
Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infectionSahil Khanna, Emmanuel Montassier, Bradley Schmidt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2018
Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and MetaanalysisRaseen Tariq, Janice Cho, Saloni Kapoor, et al.
Therapeutic Advances in Gastroenterology|March 22, 2021
Efficacy of oral vancomycin prophylaxis for prevention of <i>Clostridioides difficile</i> infection: a systematic review and meta-analysisRaseen Tariq, Maryrose Laguio-Vila, Muhammad Waqas Tahir, et al.
Mayo Clinic Proceedings|November 7, 2012
Clostridium difficile infection in patients with chronic kidney diseaseMira T Keddis, Sahil Khanna, Amit Noheria, et al.
Mayo Clinic Proceedings|June 5, 2021
Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and RecommendationsSahil Khanna, Aaron Tande, David T Rubin, et al.
Therapeutic Advances in Gastroenterology|December 15, 2022
Impact of recurrent hospitalization for <i>Clostridioides difficile</i> on longitudinal outcomes in patients with inflammatory bowel diseases: a nationally representative cohortPreethi G Venkat, Nghia H Nguyen, Jiyu Luo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile InfectionErik R Dubberke, Christine H Lee, Robert Orenstein, et al.
Pageof 38